Last Updated

14 Dec 2018

WHO Evidence Review Group meeting report: Mass drug administration, mass screening and treatment and focal screening and treatment for malaria

Click on the image above to open the resource:

WHO Evidence Review Group meeting report: Mass drug administration, mass screening and treatment and focal screening and treatment for malaria

Mass drug administration (MDA) has received renewed interest over the past decade in the context of malaria elimination, as part of multidrug resistance containment and (more recently) in emergency situations such as the West African Ebola outbreak.

To develop WHO recommendations, a group of experts met in April 2015 to review recent evidence on the use of MDA, mass screening and treatment (MSAT) and focal screening and treatment (FSAT) in specific epidemiological settings.

The following recommendations were proposed by the WHO evidence review group, for consideration by the WHO Malaria Policy Advisory Committee.

Date Published